Sharon Leslie Bober, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sexual Dysfunction, Physiological | 24 | 2024 | 355 | 7.120 |
Why?
|
Sexual Dysfunctions, Psychological | 17 | 2024 | 189 | 5.080 |
Why?
|
Sexuality | 8 | 2019 | 179 | 2.320 |
Why?
|
Survivors | 19 | 2024 | 2369 | 1.870 |
Why?
|
Sexual Behavior | 18 | 2022 | 2178 | 1.720 |
Why?
|
Neoplasms | 27 | 2024 | 22083 | 1.330 |
Why?
|
Health Communication | 3 | 2022 | 213 | 1.160 |
Why?
|
Fellowships and Scholarships | 2 | 2024 | 1117 | 0.870 |
Why?
|
Ovarian Neoplasms | 7 | 2023 | 4879 | 0.770 |
Why?
|
Medical Oncology | 3 | 2024 | 2318 | 0.760 |
Why?
|
Breast Neoplasms | 17 | 2022 | 20985 | 0.760 |
Why?
|
Body Image | 5 | 2020 | 638 | 0.720 |
Why?
|
Hematology | 1 | 2024 | 244 | 0.700 |
Why?
|
Communication | 11 | 2023 | 3868 | 0.700 |
Why?
|
Urologic Diseases | 1 | 2021 | 247 | 0.630 |
Why?
|
Psychotherapy, Group | 2 | 2019 | 412 | 0.610 |
Why?
|
Ovary | 2 | 2019 | 958 | 0.600 |
Why?
|
Quality of Life | 14 | 2024 | 13338 | 0.600 |
Why?
|
Health Personnel | 3 | 2021 | 3331 | 0.590 |
Why?
|
Self Efficacy | 2 | 2019 | 635 | 0.570 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2016 | 1517 | 0.530 |
Why?
|
Vaginal Diseases | 2 | 2016 | 103 | 0.520 |
Why?
|
Communication Barriers | 2 | 2021 | 413 | 0.520 |
Why?
|
Ovariectomy | 3 | 2023 | 614 | 0.510 |
Why?
|
Patient Education as Topic | 5 | 2017 | 2318 | 0.510 |
Why?
|
Libido | 1 | 2015 | 119 | 0.490 |
Why?
|
Salpingectomy | 1 | 2014 | 45 | 0.480 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 824 | 0.470 |
Why?
|
Menopause, Premature | 1 | 2015 | 124 | 0.460 |
Why?
|
Directive Counseling | 1 | 2014 | 170 | 0.430 |
Why?
|
Hodgkin Disease | 2 | 2010 | 1378 | 0.370 |
Why?
|
Physician-Patient Relations | 8 | 2023 | 3246 | 0.360 |
Why?
|
Attitude of Health Personnel | 4 | 2021 | 3880 | 0.360 |
Why?
|
Vagina | 1 | 2016 | 838 | 0.360 |
Why?
|
Physicians, Family | 2 | 2009 | 349 | 0.360 |
Why?
|
Stress, Psychological | 4 | 2021 | 4475 | 0.340 |
Why?
|
Interpersonal Relations | 5 | 2020 | 1436 | 0.330 |
Why?
|
Risk Reduction Behavior | 2 | 2022 | 1112 | 0.330 |
Why?
|
Gift Giving | 1 | 2009 | 76 | 0.310 |
Why?
|
Female | 46 | 2024 | 391875 | 0.310 |
Why?
|
Genetic Testing | 2 | 2020 | 3535 | 0.300 |
Why?
|
Pediatrics | 2 | 2020 | 3593 | 0.290 |
Why?
|
Adult | 34 | 2024 | 220781 | 0.290 |
Why?
|
Humans | 65 | 2024 | 760437 | 0.290 |
Why?
|
Mental Health | 1 | 2021 | 3241 | 0.270 |
Why?
|
Genes, BRCA2 | 1 | 2009 | 602 | 0.250 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 926 | 0.240 |
Why?
|
Genes, BRCA1 | 1 | 2009 | 765 | 0.240 |
Why?
|
Young Adult | 16 | 2024 | 59068 | 0.240 |
Why?
|
Qualitative Research | 4 | 2019 | 3008 | 0.230 |
Why?
|
Tamoxifen | 2 | 2007 | 964 | 0.230 |
Why?
|
Genetic Counseling | 1 | 2007 | 625 | 0.220 |
Why?
|
Sexual Partners | 5 | 2022 | 795 | 0.210 |
Why?
|
Health Care Surveys | 2 | 2016 | 2425 | 0.210 |
Why?
|
Couples Therapy | 2 | 2018 | 38 | 0.190 |
Why?
|
Health Services Research | 1 | 2009 | 1811 | 0.190 |
Why?
|
Adolescent | 15 | 2024 | 88196 | 0.190 |
Why?
|
Prostatic Neoplasms | 5 | 2022 | 11095 | 0.180 |
Why?
|
Patient Satisfaction | 2 | 2017 | 3457 | 0.180 |
Why?
|
Adaptation, Psychological | 3 | 2022 | 2629 | 0.180 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 245 | 0.170 |
Why?
|
Male | 26 | 2024 | 360035 | 0.170 |
Why?
|
Mastectomy | 3 | 2015 | 1822 | 0.170 |
Why?
|
Antineoplastic Agents | 4 | 2023 | 13616 | 0.160 |
Why?
|
Spouses | 2 | 2018 | 282 | 0.160 |
Why?
|
Personal Satisfaction | 2 | 2014 | 642 | 0.160 |
Why?
|
Motivation | 1 | 2009 | 2006 | 0.160 |
Why?
|
Neoplasms, Second Primary | 1 | 2007 | 1051 | 0.160 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 249 | 0.150 |
Why?
|
Fertility | 2 | 2016 | 771 | 0.150 |
Why?
|
Memory | 1 | 2007 | 2182 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 532 | 0.140 |
Why?
|
Telephone | 2 | 2018 | 626 | 0.140 |
Why?
|
Complementary Therapies | 1 | 2021 | 486 | 0.140 |
Why?
|
Psychotherapy, Brief | 1 | 2017 | 118 | 0.130 |
Why?
|
Primary Health Care | 1 | 2013 | 4674 | 0.130 |
Why?
|
Vulvar Diseases | 1 | 2016 | 62 | 0.130 |
Why?
|
Estrogen Antagonists | 1 | 2015 | 150 | 0.120 |
Why?
|
Infertility, Male | 1 | 2018 | 396 | 0.120 |
Why?
|
Decision Making | 2 | 2009 | 3923 | 0.120 |
Why?
|
Age Factors | 3 | 2017 | 18379 | 0.120 |
Why?
|
Anxiety | 3 | 2021 | 4558 | 0.110 |
Why?
|
Middle Aged | 15 | 2024 | 220382 | 0.110 |
Why?
|
Cryopreservation | 1 | 2019 | 725 | 0.110 |
Why?
|
Consumer Health Information | 1 | 2016 | 215 | 0.110 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2019 | 1147 | 0.110 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1407 | 0.110 |
Why?
|
Pilot Projects | 4 | 2023 | 8611 | 0.100 |
Why?
|
Mass Screening | 2 | 2011 | 5424 | 0.100 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2011 | 109 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2009 | 7380 | 0.100 |
Why?
|
Delivery of Health Care | 1 | 2009 | 5332 | 0.100 |
Why?
|
Self Concept | 1 | 2017 | 1043 | 0.090 |
Why?
|
Amenorrhea | 1 | 2014 | 483 | 0.090 |
Why?
|
Radiotherapy | 1 | 2017 | 1498 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 7996 | 0.090 |
Why?
|
Women's Health | 2 | 2017 | 2065 | 0.090 |
Why?
|
BRCA2 Protein | 1 | 2014 | 799 | 0.080 |
Why?
|
Models, Psychological | 1 | 2013 | 829 | 0.080 |
Why?
|
Aged | 9 | 2024 | 168840 | 0.080 |
Why?
|
Sexual Development | 1 | 2009 | 40 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 5 | 2023 | 17854 | 0.080 |
Why?
|
Colorado | 1 | 2009 | 165 | 0.080 |
Why?
|
Patient Preference | 1 | 2016 | 924 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1598 | 0.080 |
Why?
|
Postal Service | 1 | 2009 | 96 | 0.080 |
Why?
|
Fallopian Tubes | 1 | 2009 | 177 | 0.080 |
Why?
|
Menopause | 1 | 2016 | 1645 | 0.070 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1146 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2018 | 5236 | 0.070 |
Why?
|
Professional Practice | 1 | 2009 | 313 | 0.070 |
Why?
|
United States | 3 | 2024 | 72202 | 0.070 |
Why?
|
Marriage | 1 | 2009 | 351 | 0.070 |
Why?
|
Arousal | 1 | 2012 | 1162 | 0.070 |
Why?
|
Depression | 2 | 2021 | 8104 | 0.070 |
Why?
|
Mammography | 2 | 2007 | 2426 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5663 | 0.070 |
Why?
|
Boston | 2 | 2010 | 9326 | 0.070 |
Why?
|
Child | 4 | 2024 | 80086 | 0.060 |
Why?
|
Long-Term Care | 1 | 2009 | 633 | 0.060 |
Why?
|
Culture | 1 | 2009 | 623 | 0.060 |
Why?
|
Prospective Studies | 3 | 2024 | 54339 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3027 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39078 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8623 | 0.060 |
Why?
|
Data Collection | 2 | 2010 | 3321 | 0.060 |
Why?
|
Risk Factors | 4 | 2020 | 74055 | 0.060 |
Why?
|
Disease Management | 1 | 2013 | 2501 | 0.050 |
Why?
|
Physician's Role | 1 | 2009 | 916 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2007 | 1155 | 0.050 |
Why?
|
Chemoprevention | 1 | 2004 | 326 | 0.050 |
Why?
|
Internal Medicine | 1 | 2009 | 1051 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10180 | 0.050 |
Why?
|
Internet | 2 | 2017 | 3092 | 0.050 |
Why?
|
Fatigue | 1 | 2008 | 1550 | 0.050 |
Why?
|
Orgasm | 1 | 2020 | 61 | 0.050 |
Why?
|
Focus Groups | 2 | 2017 | 1404 | 0.050 |
Why?
|
Medical History Taking | 1 | 2004 | 773 | 0.050 |
Why?
|
Cohort Studies | 3 | 2014 | 41366 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8522 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2012 | 3728 | 0.040 |
Why?
|
Prevalence | 2 | 2020 | 15698 | 0.040 |
Why?
|
Massachusetts | 1 | 2012 | 8826 | 0.040 |
Why?
|
Premenopause | 1 | 2023 | 1039 | 0.040 |
Why?
|
Puberty | 1 | 2021 | 501 | 0.040 |
Why?
|
Learning | 1 | 2007 | 1740 | 0.040 |
Why?
|
Contraception | 1 | 2021 | 348 | 0.040 |
Why?
|
Mutation | 2 | 2014 | 30025 | 0.040 |
Why?
|
Mental Health Services | 1 | 2008 | 1730 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14565 | 0.030 |
Why?
|
Counseling | 1 | 2004 | 1545 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2012 | 58859 | 0.030 |
Why?
|
Logistic Models | 1 | 2010 | 13240 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3596 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 765 | 0.030 |
Why?
|
Risk | 1 | 2007 | 9605 | 0.030 |
Why?
|
Needs Assessment | 1 | 2021 | 1139 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15627 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2009 | 4316 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3115 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2010 | 22097 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2022 | 1443 | 0.020 |
Why?
|
Life Style | 1 | 2022 | 3909 | 0.020 |
Why?
|
Emotions | 1 | 2022 | 2735 | 0.020 |
Why?
|
Child, Preschool | 2 | 2017 | 42209 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1403 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3183 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3344 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 29831 | 0.020 |
Why?
|
Age of Onset | 1 | 2011 | 3302 | 0.010 |
Why?
|
Psychometrics | 1 | 2011 | 3063 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26063 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6894 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14661 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36183 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 64591 | 0.010 |
Why?
|